Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to compare different timing therapies of Verteporfin
with Bevacizumab to treat choroidal neovascularization (CNV) due to age-related macular
degeneration (AMD).